Analysts took a close look at Novo Nordisk shares last month.
32 experts published their stock analysis of Novo Nordisk last month.
11 experts classify the Novo Nordisk share as a buy, 20 analysts classify the Novo Nordisk shares as a hold, and 1 expert recommends selling the shares.
The experts’ average price target is DKK 336.75. This equates to a discount of DKK 64.60 to the current CPH price of the Novo Nordisk share of DKK 401.35.
The 6-month rating trend is Buy.
| Analyst | Price target | Distance price target | Date | |
|---|---|---|---|---|
| Barclays Capital | 270.00 DKK | -32.73 | 02/27/2026 | |
| Goldman Sachs Group Inc. | 400.00 DKK | -0.34 | 02/24/2026 | |
| JP Morgan Chase & Co. | 250.00 DKK | -37.71 | 02/24/2026 | |
| JP Morgan Chase & Co. | 250.00 DKK | -37.71 | 02/24/2026 | |
| Barclays Capital | 270.00 DKK | -32.73 | 02/24/2026 | |
| Deutsche Bank AG | 275.00 DKK | -31.48 | 02/23/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/23/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/23/2026 | |
| Jefferies & Company Inc. | 275.00 DKK | -31.48 | 02/23/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/23/2026 | |
| UBS AG | 332.00 DKK | -17.28 | 02/23/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/23/2026 | |
| Goldman Sachs Group Inc. | 400.00 DKK | -0.34 | 02/23/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/19/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/18/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/17/2026 | |
| Barclays Capital | 340.00 DKK | -15.29 | 02/13/2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 360.00 DKK | -10.30 | 02/12/2026 | |
| Jefferies & Company Inc. | 275.00 DKK | -31.48 | 02/12/2026 | |
| Deutsche Bank AG | 400.00 DKK | -0.34 | 02/11/2026 | |
| Barclays Capital | 360.00 DKK | -10.30 | 02/10/2026 | |
| Barclays Capital | 360.00 DKK | -10.30 | 02/09/2026 | |
| UBS AG | 332.00 DKK | -17.28 | 02/06/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/06/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/06/2026 | |
| Deutsche Bank AG | 475.00 DKK | 18.35 | 02/05/2026 | |
| UBS AG | 332.00 DKK | -17.28 | 02/05/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/04/2026 | |
| Jefferies & Company Inc. | 270.00 DKK | -32.73 | 02/03/2026 | |
| Barclays Capital | 360.00 DKK | -10.30 | 02/03/2026 | |
| JP Morgan Chase & Co. | 350.00 DKK | -12.79 | 02/02/2026 | |
| UBS AG | 390.00 DKK | -2.83 | 02/02/2026 |
Editorial team finanzen.net
Selected leverage products on Novo Nordisk
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Novo Nordisk
The leverage must be between 2 and 20
Advertising
